Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient’s
Sr Mgr, Health Economic & Reimbursement This role represents an opportunity to join the Global Health Economics & Reimbursement (GHER) team supporting patient access to innovative transcatheter mitral and tricuspid valve technologies (TMTT) at Edwards Lifesciences. Position Summary: